DrugPatentWatch Database Preview
TECHNIVIE Drug Profile
When do Technivie patents expire, and when can generic versions of Technivie launch?
Technivie is a drug marketed by Abbvie Inc and is included in one NDA. There are ten patents protecting this drug.
This drug has three hundred and sixty patent family members in forty-five countries.
The generic ingredient in TECHNIVIE is ombitasvir; paritaprevir; ritonavir. One supplier is listed for this compound. Additional details are available on the ombitasvir; paritaprevir; ritonavir profile page.
Summary for TECHNIVIE
| International Patents: | 360 |
| US Patents: | 10 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 2 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TECHNIVIE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TECHNIVIE |
| DailyMed Link: | TECHNIVIE at DailyMed |
Generic Entry Opportunity Date for TECHNIVIE
Generic Entry Date for TECHNIVIE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for TECHNIVIE
Expired US Patents for TECHNIVIE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Abbvie Inc | TECHNIVIE | ombitasvir; paritaprevir; ritonavir | TABLET;ORAL | 207931-001 | Jul 24, 2015 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Abbvie Inc | TECHNIVIE | ombitasvir; paritaprevir; ritonavir | TABLET;ORAL | 207931-001 | Jul 24, 2015 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for TECHNIVIE
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Peru | 01232010 | ➤ Try a Free Trial |
| Eurasian Patent Organization | 201170401 | ➤ Try a Free Trial |
| Canada | 2837129 | ➤ Try a Free Trial |
| Japan | 5834085 | ➤ Try a Free Trial |
| Japan | 5259537 | ➤ Try a Free Trial |
| Japan | 5906253 | ➤ Try a Free Trial |
| South Africa | 200707022 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for TECHNIVIE
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 90050-7 | Sweden | ➤ Try a Free Trial | PRODUCT NAME: PIBRENTASVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/17/1213 20170728 |
| 2368890/01 | Switzerland | ➤ Try a Free Trial | PRODUCT NAME: OMBITASVIR; REGISTRATION NO/DATE: SWISSMEDIC 65301 25.11.2014 |
| /2017 | Austria | ➤ Try a Free Trial | PRODUCT NAME: PIBRENTASVIR ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/17/1213 (MITTEILUNG) 20170728 |
| 0901 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: PIBRENTASVIR OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/17/1213 20170728 |
| 2015 00013 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: PARITAPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER THEROF; REG. NO/DATE: EU/1/14/982 20150115 |
| 2017000074 | Germany | ➤ Try a Free Trial | PRODUCT NAME: PIBRENTASVIR ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/17/1213 20170726 |
| 2015 00013 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: PARITAPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER THEROF; REG. NO/DATE: EU/1/14/982 20150119 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
